Cencora Inc (COR)

$294.65 -2.41 (-0.81%)
Market Cap 57.22B
Revenue (ttm) 293.96B
Net Income (ttm) 1.51B
EPS (ttm) N/A
PE Ratio 20.05
Forward PE 18.81
Profit Margin 0.51%
Debt to Equity Ratio 6.66
Volume 916,423
Avg Vol 1,513,570
Day's Range N/A - N/A
Shares Out 193.82M
Stochastic %K 57%
Beta 0.57
Analysts Strong Sell
Price Target $331.79

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
ZacksResearch
ZacksResearch Jul. 11 at 4:55 PM
$COR up 32.4% YTD — Can it keep the pace? 🚀 🔹 Strong U.S. Healthcare Solutions driving growth 🔹 Adjusted EPS projected to rise 14-16% in FY2025 🔹 Recent acquisition expands specialty capabilities Discover the full growth story here 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2573188-body-1317&ADID=SYND_STOCKTWITS_TWEET_2_2573188_BODY_1317
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:44 PM
$COR is riding a strong growth wave — but is it enough? GLP-1 and specialty drug sales are fueling gains, making it a compelling pick now. But margin pressure and tough competition still loom large. See if the reward outweighs the risk 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-0-2573188-teaser-1289&ADID=SYND_STOCKTWITS_TWEET_0_2573188_TEASER_1289
0 · Reply
Rayyleeee
Rayyleeee Jul. 10 at 9:43 PM
$CRWV $COR next catalyst should be their official announcement of a large-scale contract with Google this or next quarter...
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 8:07 PM
Cencora ($COR) expands receivables facility to $1.5B with enhanced accordion flexibility. While this boosts liquidity for pharma distribution ops, the debt-heavy balance sheet (7.76x D/E ratio) still looms large. Clever financial engineering or kicking the can? Market will decide. https://www.sec.gov/Archives/edgar/data/1140859/000110465925065769/tm2519648d1_8k.htm
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting 3.82 EPS for $COR Q3 [Reporting 07/30 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Jun. 30 at 2:54 PM
Jefferies has adjusted their stance on Cencora ( $COR ), setting the rating to Hold with a target price of 275 → 300.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 2:53 PM
$COR Jefferies Maintains Hold on Cencora, Raises Price Target to $300
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 6:53 PM
$COR Deep Dive https://youtu.be/bslxGpFMPJs?si=HBEUX6fFQVSNkmBL
0 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
Latest News on COR
Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Jul 3, 2025, 7:30 AM EDT - 12 days ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 6 weeks ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 16, 2025, 8:37 AM EDT - 2 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 2:06 PM EDT - 2 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 2 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty drugs

May 7, 2025, 7:27 AM EDT - 2 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 2 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 3 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 3 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Mar 28, 2025, 7:00 AM EDT - 3 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 4 months ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:37 PM EST - 5 months ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

Feb 6, 2025, 8:30 PM EST - 5 months ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 6, 2025, 8:30 AM EST - 5 months ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 5 months ago

Cencora (COR) Q1 2025 Earnings Call Transcript

Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 5 months ago

Cencora raises 2025 profit forecast on specialty drug demand

Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 5 months ago

Cencora Reports Fiscal 2025 First Quarter Results

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Jan 27, 2025, 7:30 AM EST - 6 months ago

Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

HROW

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

Jan 13, 2025, 12:07 PM EST - 6 months ago

Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth

COST DHR EL MSGS WST

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Jan 8, 2025, 7:30 AM EST - 6 months ago

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 6 months ago

Cencora raises annual profit forecast

Cencora Completes Acquisition of Retina Consultants of America

Jan 2, 2025, 4:15 PM EST - 6 months ago

Cencora Completes Acquisition of Retina Consultants of America

Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 7 months ago

Cencora Closes $1.8 Billion Senior Notes Offering

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Dec 6, 2024, 8:30 AM EST - 7 months ago

Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers

Cencora: Competitive Advantages Defined

Dec 5, 2024, 10:26 AM EST - 7 months ago

Cencora: Competitive Advantages Defined

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Dec 2, 2024, 10:49 PM EST - 8 months ago

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 8 months ago

Cencora to Host Inaugural Product Showcase

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Nov 6, 2024, 11:38 AM EST - 8 months ago

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Nov 6, 2024, 10:56 AM EST - 8 months ago

Cencora, Inc. (COR) Q4 2024 Earnings Call Transcript

Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:54 AM EST - 8 months ago

Cencora to buy Retina Consultants of America for $4.6 bln

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Nov 6, 2024, 6:35 AM EST - 8 months ago

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Nov 6, 2024, 6:30 AM EST - 8 months ago

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Nov 4, 2024, 8:30 AM EST - 9 months ago

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Dividend Aristocrats Of The Future - Part 3

Nov 1, 2024, 4:42 PM EDT - 9 months ago

Dividend Aristocrats Of The Future - Part 3

AIZ COST CSX DUK K RSG SRE

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Oct 1, 2024, 7:30 AM EDT - 10 months ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

Sep 10, 2024, 8:30 AM EDT - 11 months ago

Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents

Cencora Elects Frank Clyburn to Its Board of Directors

Aug 15, 2024, 7:30 AM EDT - 11 months ago

Cencora Elects Frank Clyburn to Its Board of Directors

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

Aug 14, 2024, 9:00 AM EDT - 11 months ago

Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

Aug 2, 2024, 1:59 PM EDT - 1 year ago

Walgreens continues to shed stake in Cencora as it looks to bolster turnaround

WBA

Pharma giant Cencora is alerting millions about its data breach

Aug 2, 2024, 10:45 AM EDT - 1 year ago

Pharma giant Cencora is alerting millions about its data breach

Walgreens further reduces stake in Cencora

Aug 1, 2024, 6:20 PM EDT - 1 year ago

Walgreens further reduces stake in Cencora

WBA

Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds

Aug 1, 2024, 6:08 PM EDT - 1 year ago

Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds

WBA

Cencora says additional data stolen in February cyberattack

Jul 31, 2024, 6:14 PM EDT - 1 year ago

Cencora says additional data stolen in February cyberattack

Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript

Jul 31, 2024, 11:12 AM EDT - 1 year ago

Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty medicines

Jul 31, 2024, 7:54 AM EDT - 1 year ago

Cencora raises annual profit forecast on strong demand for specialty medicines

Cencora Reports Fiscal 2024 Third Quarter Results

Jul 31, 2024, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2024 Third Quarter Results

The Highest Quality Dividend Growth Stocks In 2024

Jul 9, 2024, 9:00 AM EDT - 1 year ago

The Highest Quality Dividend Growth Stocks In 2024

AAPL ACN ADP AJG AON AOS APD

Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release

Cencora: Long-Term Compounder With Mouth-Watering Economics

Jun 24, 2024, 12:20 PM EDT - 1 year ago

Cencora: Long-Term Compounder With Mouth-Watering Economics

AmerisourceBergen Specialty Group Substitute Notice of Data Incident to Affected Individuals

Jun 4, 2024, 5:30 PM EDT - 1 year ago

AmerisourceBergen Specialty Group Substitute Notice of Data Incident to Affected Individuals

ZacksResearch
ZacksResearch Jul. 11 at 4:55 PM
$COR up 32.4% YTD — Can it keep the pace? 🚀 🔹 Strong U.S. Healthcare Solutions driving growth 🔹 Adjusted EPS projected to rise 14-16% in FY2025 🔹 Recent acquisition expands specialty capabilities Discover the full growth story here 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2573188-body-1317&ADID=SYND_STOCKTWITS_TWEET_2_2573188_BODY_1317
0 · Reply
ZacksResearch
ZacksResearch Jul. 11 at 12:44 PM
$COR is riding a strong growth wave — but is it enough? GLP-1 and specialty drug sales are fueling gains, making it a compelling pick now. But margin pressure and tough competition still loom large. See if the reward outweighs the risk 👉 https://www.zacks.com/stock/news/2573188/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-0-2573188-teaser-1289&ADID=SYND_STOCKTWITS_TWEET_0_2573188_TEASER_1289
0 · Reply
Rayyleeee
Rayyleeee Jul. 10 at 9:43 PM
$CRWV $COR next catalyst should be their official announcement of a large-scale contract with Google this or next quarter...
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 3 at 8:07 PM
Cencora ($COR) expands receivables facility to $1.5B with enhanced accordion flexibility. While this boosts liquidity for pharma distribution ops, the debt-heavy balance sheet (7.76x D/E ratio) still looms large. Clever financial engineering or kicking the can? Market will decide. https://www.sec.gov/Archives/edgar/data/1140859/000110465925065769/tm2519648d1_8k.htm
0 · Reply
Estimize
Estimize Jul. 2 at 10:00 PM
Wall St is expecting 3.82 EPS for $COR Q3 [Reporting 07/30 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Jun. 30 at 2:54 PM
Jefferies has adjusted their stance on Cencora ( $COR ), setting the rating to Hold with a target price of 275 → 300.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 30 at 2:53 PM
$COR Jefferies Maintains Hold on Cencora, Raises Price Target to $300
0 · Reply
StockAnalyticsAI
StockAnalyticsAI Jun. 23 at 6:53 PM
$COR Deep Dive https://youtu.be/bslxGpFMPJs?si=HBEUX6fFQVSNkmBL
0 · Reply
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
harmongreg
harmongreg Jun. 15 at 3:44 PM
5 Trade Ideas for Monday: Antero, Cencora, CVS, J&J and Marathon Petroleum $AR $COR $CVS $JNJ $MPC https://dragonflycap.com/5-trade-ideas-for-monday-antero-cencora-cvs-jj-and-marathon-petroleum/
0 · Reply
QuiverQuant
QuiverQuant Jun. 6 at 2:57 PM
New Analyst Forecast: $COR Given 'Overweight' Rating Read more on $COR: https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24COR+Given+%27Overweight%27+Rating
0 · Reply
erevnon
erevnon Jun. 3 at 2:43 PM
Wells Fargo upgrades Cencora $COR from Equal-Weight to Overweight and raises the price target from $274 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo updates rating for Cencora ( $COR ) to Overweight, target set at 274 → 337.
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 2:16 PM
$COR up 29.4% YTD—what's driving this rally? 🚀 🌟 Strong U.S. Healthcare Solutions performance 💊 Specialty & GLP-1 medications boost growth 📈 Adjusted EPS projected to rise 14-16% in fiscal 2025 See why Cencora is a Zacks Rank #2 Buy 👉 https://www.zacks.com/commentary/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-body&ADID=SYND_STOCKTWITS_TWEET_2_2479450_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 30 at 12:54 PM
$COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe. Read the full story here: https://www.zacks.com/stock/news/2479450/heres-why-you-should-add-cencora-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2479450-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479450_TEASER
0 · Reply
TradeInYourJob
TradeInYourJob May. 30 at 12:33 AM
$COR Sell Signal on the weekly timeframe CCI and negative divergence in the onbalance volume.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 21 at 11:31 AM
Is $COR maintaining its trajectory within the projected Post-Earnings Announcement Drift (PEAD) cone? Monitoring whether the stock's price action remains within this forecasted range helps assess the accuracy of the earnings-based predictive model and potential deviations in momentum. #stocks #trading #investing
0 · Reply
NxtBgThng
NxtBgThng May. 17 at 2:19 AM
$OTLK started buying $COR when Outlook hired them to market lytenava as buyout rumors were swirling. Has worked out well.
0 · Reply
CLiZzY
CLiZzY May. 15 at 2:53 PM
$COR looks pretty solid
0 · Reply
IN0V8
IN0V8 May. 12 at 4:50 PM
$COR JP Morgan raises target price to $326 from $301
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 2:58 PM
$UNH $CI $CAH $COR $MCK Trump says will 'cut out middlemen' to reduce drug prices President Donald Trump made the comment while speaking from the White House.
0 · Reply
1986iamwallstreet
1986iamwallstreet May. 12 at 2:26 PM
$COR bleeding 🩸
0 · Reply